SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-030513
Filing Date
2021-12-03
Accepted
2021-12-03 19:58:43
Documents
1
Period of Report
2021-12-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6848
  Complete submission text file 0001493152-21-030513.txt   8717
Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Reporting) CIK: 0001640809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 211471643

Mailing Address 1455 NW LEARY WAY, SUITE 400 SEATTLE WA 98107
Business Address
English Aron R. (Reporting) CIK: 0001770436 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 211471644

Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations